EP2068861A4 - Compositions comprenant des acides gras oméga-3 et utilisation de celles-ci dans le traitement d'une maladie des artères périphériques et d'une claudication intermittente - Google Patents
Compositions comprenant des acides gras oméga-3 et utilisation de celles-ci dans le traitement d'une maladie des artères périphériques et d'une claudication intermittenteInfo
- Publication number
- EP2068861A4 EP2068861A4 EP07810680A EP07810680A EP2068861A4 EP 2068861 A4 EP2068861 A4 EP 2068861A4 EP 07810680 A EP07810680 A EP 07810680A EP 07810680 A EP07810680 A EP 07810680A EP 2068861 A4 EP2068861 A4 EP 2068861A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- omega
- compositions
- fatty acids
- artery disease
- peripheral artery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83213506P | 2006-07-21 | 2006-07-21 | |
PCT/US2007/016526 WO2008011178A2 (fr) | 2006-07-21 | 2007-07-23 | Compositions comprenant des acides gras oméga-3 et utilisation de celles-ci dans le traitement d'une maladie des artères périphériques et d'une claudication intermittente |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2068861A2 EP2068861A2 (fr) | 2009-06-17 |
EP2068861A4 true EP2068861A4 (fr) | 2010-01-06 |
Family
ID=38957420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07810680A Withdrawn EP2068861A4 (fr) | 2006-07-21 | 2007-07-23 | Compositions comprenant des acides gras oméga-3 et utilisation de celles-ci dans le traitement d'une maladie des artères périphériques et d'une claudication intermittente |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2068861A4 (fr) |
JP (1) | JP2009544701A (fr) |
WO (1) | WO2008011178A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8343753B2 (en) | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
JP6176894B2 (ja) * | 2009-03-09 | 2017-08-09 | プロノヴァ・バイオファーマ・ノルゲ・アーエス | 脂肪酸油混合物及び界面活性剤を含む組成物、並びにその方法及び使用 |
WO2016152054A1 (fr) * | 2015-03-26 | 2016-09-29 | 備前化成株式会社 | Effets de prévention et d'atténuation de la douleur du glycéride d'acide gras ω3 |
WO2020037153A1 (fr) * | 2018-08-17 | 2020-02-20 | Amarin Pharmaceuticals Ireland Limited | Méthodes de réduction du besoin de revascularisation artérielle périphérique chez un sujet traité par des statines |
KR20240012390A (ko) | 2021-04-21 | 2024-01-29 | 애머린 파마슈티칼스 아일랜드 리미티드 | 심부전의 위험을 감소시키는 방법 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1125914A1 (fr) * | 2000-02-14 | 2001-08-22 | Nisshin Flour Milling Co., Ltd. | Procédé de séparation et de purification d'acide eicosapentaénoique ou d'un ester de celui-ci |
US20020055539A1 (en) * | 1996-10-02 | 2002-05-09 | Bockow Barry I. | Compositions and methods for treating cardiovascular conditions |
WO2006062748A2 (fr) * | 2004-12-06 | 2006-06-15 | Reliant Pharmaceuticals, Inc. | Acides gras omega-3 et agent dyslipidemique pour therapie lipidique |
WO2006062932A2 (fr) * | 2004-12-06 | 2006-06-15 | Reliant Pharmaceuticals, Inc. | Traitement au moyen d'acides gras omega-3 et d'un agoniste et/ou antagoniste ppar et produit composite de ceux-ci |
WO2006096806A2 (fr) * | 2005-03-08 | 2006-09-14 | Reliant Pharmaceutiacals, Inc. | Traitement avec une statine et des acides gras omega 3 et produit de combinaison correspondant |
WO2007011886A2 (fr) * | 2005-07-18 | 2007-01-25 | Reliant Pharmaceuticals, Inc. | Traitement au moyen d'inhibiteurs d'absorption de cholesterol a base d'azetidinone et d'acide gras omega-3 et produit de combinaison de ceux-ci |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8819110D0 (en) * | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
US5532003A (en) * | 1994-01-18 | 1996-07-02 | Alza Corporation | Pentoxifylline therapy |
-
2007
- 2007-07-23 WO PCT/US2007/016526 patent/WO2008011178A2/fr active Application Filing
- 2007-07-23 EP EP07810680A patent/EP2068861A4/fr not_active Withdrawn
- 2007-07-23 JP JP2009521785A patent/JP2009544701A/ja active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020055539A1 (en) * | 1996-10-02 | 2002-05-09 | Bockow Barry I. | Compositions and methods for treating cardiovascular conditions |
EP1125914A1 (fr) * | 2000-02-14 | 2001-08-22 | Nisshin Flour Milling Co., Ltd. | Procédé de séparation et de purification d'acide eicosapentaénoique ou d'un ester de celui-ci |
WO2006062748A2 (fr) * | 2004-12-06 | 2006-06-15 | Reliant Pharmaceuticals, Inc. | Acides gras omega-3 et agent dyslipidemique pour therapie lipidique |
WO2006062932A2 (fr) * | 2004-12-06 | 2006-06-15 | Reliant Pharmaceuticals, Inc. | Traitement au moyen d'acides gras omega-3 et d'un agoniste et/ou antagoniste ppar et produit composite de ceux-ci |
WO2006096806A2 (fr) * | 2005-03-08 | 2006-09-14 | Reliant Pharmaceutiacals, Inc. | Traitement avec une statine et des acides gras omega 3 et produit de combinaison correspondant |
WO2007011886A2 (fr) * | 2005-07-18 | 2007-01-25 | Reliant Pharmaceuticals, Inc. | Traitement au moyen d'inhibiteurs d'absorption de cholesterol a base d'azetidinone et d'acide gras omega-3 et produit de combinaison de ceux-ci |
Also Published As
Publication number | Publication date |
---|---|
EP2068861A2 (fr) | 2009-06-17 |
WO2008011178A2 (fr) | 2008-01-24 |
JP2009544701A (ja) | 2009-12-17 |
WO2008011178A3 (fr) | 2008-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1919468A4 (fr) | Traitement au moyen d'inhibiteurs d'absorption de cholesterol a base d'azetidinone et d'acide gras omega-3 et produit de combinaison de ceux-ci | |
ZA201003030B (en) | Medium-chain length fatty acids and glycerides as nephroprotection agents | |
EP2041047A4 (fr) | Melanges d'acides gras et leurs utilisations | |
IL240454A0 (en) | Propanesulfonic acids and their 1-amino-3 use in the preparation of medicines | |
ZA200903860B (en) | Treatment of PRDC in pigs | |
PL2390339T3 (pl) | Delta-8 desaturazy i ich zastosowanie w wytwarzaniu polinienasyconych kwasów tłuszczowych | |
ZA200900334B (en) | DHA esters and use thereof in treatment and prevention of cardiovascular disease | |
EP2185202A4 (fr) | Utilisation de l'interleukine-22 dans le traitement de la stéatose hépatique | |
EP1861087A4 (fr) | Traitement avec une statine et des acides gras omega 3 et produit de combinaison correspondant | |
EP2136844A4 (fr) | Compositions comprenant des monoglycérides d'acides gras polyinsaturés ou des dérivés de ceux-ci et leurs utilisations | |
EP2046957A4 (fr) | Désaturases d'acides gras et leurs utilisations | |
EP2064550A4 (fr) | Compositions associees a prrg4 et procedes d'utilisation de celles-ci dans des procedes de diagnostic de tumeur | |
PL2214638T3 (pl) | Kompozycja zawierająca wielonienasycone kwasy tłuszczowe i węgiel aktywny | |
EP2084209A4 (fr) | Copolymère comprenant un motif de 4-hydroxybutyrate et un motif de lactate et son procédé de fabrication | |
EP2324119A4 (fr) | Delta5 désaturases mutantes et leur utilisation dans la production d'acides gras polyinsaturés | |
EP1991594A4 (fr) | Polymère hybride d'acrylate basé sur des acides gras naturels et sa méthode de fabrication | |
ZA201001473B (en) | Compositions and methods for the modification of physiological responses in plants | |
ZA200907757B (en) | Use of bipolar trans cartenoids as a pretreatment and in the treatment of peripheral vascular disease | |
HK1155167A1 (en) | Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states pde4 | |
EP2079526A4 (fr) | Compositions et leurs utilisations dans le traitement de lésions | |
CL2011000290A1 (es) | Método para extraer ácidos grasos poliinsaturados de cadena larga; composición de aceite y su uso en tratamiento cosméticos o terapéuticos. | |
ZA201305125B (en) | Compositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyperthyroidism | |
EP2068861A4 (fr) | Compositions comprenant des acides gras oméga-3 et utilisation de celles-ci dans le traitement d'une maladie des artères périphériques et d'une claudication intermittente | |
PT2842555T (pt) | Derivados-alfa de ácidos gordos cis-monoinsaturados para uso como medicamentos no tratamento de diabetes | |
EP2099295A4 (fr) | Prophylaxie et traitement de la fibrillation auriculaire avec des acides gras oméga-3 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20090218 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK RS |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20091204 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 3/06 20060101ALI20091130BHEP Ipc: A61P 3/00 20060101ALI20091130BHEP Ipc: A61P 43/00 20060101ALI20091130BHEP Ipc: A61P 9/00 20060101ALI20091130BHEP Ipc: A61K 45/06 20060101ALI20091130BHEP Ipc: A61K 31/20 20060101AFI20090302BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20100223 |